ES2082026T3 - Derivados de hidantoina. - Google Patents

Derivados de hidantoina.

Info

Publication number
ES2082026T3
ES2082026T3 ES91104195T ES91104195T ES2082026T3 ES 2082026 T3 ES2082026 T3 ES 2082026T3 ES 91104195 T ES91104195 T ES 91104195T ES 91104195 T ES91104195 T ES 91104195T ES 2082026 T3 ES2082026 T3 ES 2082026T3
Authority
ES
Spain
Prior art keywords
formula
hydrogen
compound
hydantoine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91104195T
Other languages
English (en)
Inventor
Wolfgang Dr Konig
Melitta Dr Just
Bernd Dr Jablonka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2082026T3 publication Critical patent/ES2082026T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA INVENCION: SE REFIERE A UN NUEVO DERIVADO DE HIDANTOINA DE FORMULA (I) : TRATA DE UN PROCEDIMIENTO PARA LA PRODUCCION DEL COMPUESTO DE FORMULA (I) Y DESCRIBE LA APLICACION DEL COMPUESTO DE FORMULA (I) PARA INHIBIR LA FORMACION DE TROMBOCITOS. SIENDO; R'' ALQUILO O UN RESTO DE FORMULA (II); R (AL CUADRADO) HIDROGENO, -NH-CO-NH Y OTRO; R'' Y R" HIDROGENO O ALQUILO Y N 3 O 4.
ES91104195T 1990-03-24 1991-03-19 Derivados de hidantoina. Expired - Lifetime ES2082026T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4009506A DE4009506A1 (de) 1990-03-24 1990-03-24 Hydantoinderivate

Publications (1)

Publication Number Publication Date
ES2082026T3 true ES2082026T3 (es) 1996-03-16

Family

ID=6402986

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91104195T Expired - Lifetime ES2082026T3 (es) 1990-03-24 1991-03-19 Derivados de hidantoina.

Country Status (18)

Country Link
US (1) US5686421A (es)
EP (1) EP0449079B1 (es)
JP (1) JP3003252B2 (es)
KR (1) KR100197329B1 (es)
AU (1) AU634039B2 (es)
BR (1) BR9101121A (es)
CA (1) CA2038848C (es)
DE (2) DE4009506A1 (es)
DK (1) DK0449079T3 (es)
ES (1) ES2082026T3 (es)
GR (1) GR3018826T3 (es)
IE (1) IE910958A1 (es)
IL (1) IL97657A (es)
NO (1) NO911158L (es)
NZ (1) NZ237548A (es)
PT (1) PT97114B (es)
TW (1) TW213469B (es)
ZA (1) ZA912178B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264420A (en) * 1990-09-27 1993-11-23 Merck & Co., Inc. Fibrinogen receptor antagonists
IL99537A (en) * 1990-09-27 1995-11-27 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical preparations containing them
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
DE4126277A1 (de) * 1991-08-08 1993-02-11 Cassella Ag Hydantoinderivate
DE4207254A1 (de) * 1992-03-07 1993-09-09 Cassella Ag 4-oxo-2-thioxoimidazolidin-derivate
DE4213634A1 (de) * 1992-04-24 1993-10-28 Cassella Ag 2,4-Dioxo-imidazolidin-Derivate
DE4228717A1 (de) * 1992-08-28 1994-03-03 Cassella Ag Imidazolidin-Derivate
DE4301747A1 (de) * 1993-01-23 1994-07-28 Cassella Ag Substituierte Aminoverbindungen, ihre Herstellung und ihre Verwendung
DE4308034A1 (de) * 1993-03-13 1994-09-15 Cassella Ag Neue Heterocyclen, ihre Herstellung und ihre Verwendung
DE4309867A1 (de) * 1993-03-26 1994-09-29 Cassella Ag Neue Harnstoffderivate, ihre Herstellung und Verwendung
DE4427979A1 (de) * 1993-11-15 1996-02-15 Cassella Ag Substituierte 5-Ring-Heterocyclen, ihre Herstellung und ihre Verwendung
EP0796855B1 (de) 1996-03-20 2002-02-06 Hoechst Aktiengesellschaft Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
US6384061B1 (en) * 1997-07-26 2002-05-07 Lg Chemical Ltd. Hydantoin compounds and methods related thereto
KR19990012061A (ko) * 1997-07-26 1999-02-25 성재갑 파네실 전이효소 저해제로 유용한 하이덴토인 유도체
DE19741235A1 (de) 1997-09-18 1999-03-25 Hoechst Marion Roussel De Gmbh Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19741873A1 (de) * 1997-09-23 1999-03-25 Hoechst Marion Roussel De Gmbh Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19751251A1 (de) 1997-11-19 1999-05-20 Hoechst Marion Roussel De Gmbh Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate
DE19821483A1 (de) * 1998-05-14 1999-11-18 Hoechst Marion Roussel De Gmbh Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19922462A1 (de) 1999-05-17 2000-11-23 Aventis Pharma Gmbh Spiro-imidazolidinderivate, ihre Herstellung ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10111877A1 (de) 2001-03-10 2002-09-12 Aventis Pharma Gmbh Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10137595A1 (de) * 2001-08-01 2003-02-13 Aventis Pharma Gmbh Neue Imidazolidinderivate, ihre Herstellung und ihre Verwendung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578079A (en) * 1982-08-04 1986-03-25 La Jolla Cancer Research Foundation Tetrapeptide
US4614517A (en) * 1982-08-04 1986-09-30 La Jolla Cancer Research Foundation Tetrapeptide
US4683291A (en) * 1985-10-28 1987-07-28 Scripps Clinic And Research Foundation Platelet binding inhibitors
ZW6189A1 (en) * 1988-05-09 1990-05-09 Smithkline Beckman Corp Anti-aggregatory peptides
DE4126277A1 (de) * 1991-08-08 1993-02-11 Cassella Ag Hydantoinderivate

Also Published As

Publication number Publication date
IE910958A1 (en) 1991-09-25
BR9101121A (pt) 1991-11-05
ZA912178B (en) 1991-12-24
AU634039B2 (en) 1993-02-11
KR910016709A (ko) 1991-11-05
DK0449079T3 (da) 1996-03-11
EP0449079A3 (en) 1992-08-26
NZ237548A (en) 1992-05-26
PT97114B (pt) 1998-08-31
NO911158D0 (no) 1991-03-22
GR3018826T3 (en) 1996-04-30
IL97657A (en) 1995-08-31
PT97114A (pt) 1991-11-29
EP0449079B1 (de) 1995-11-15
KR100197329B1 (ko) 1999-06-15
JPH04217962A (ja) 1992-08-07
AU7365391A (en) 1991-10-03
US5686421A (en) 1997-11-11
DE4009506A1 (de) 1991-09-26
JP3003252B2 (ja) 2000-01-24
IL97657A0 (en) 1992-06-21
CA2038848C (en) 2002-01-22
NO911158L (no) 1991-09-25
CA2038848A1 (en) 1991-09-25
TW213469B (es) 1993-09-21
EP0449079A2 (de) 1991-10-02
DE59106881D1 (de) 1995-12-21

Similar Documents

Publication Publication Date Title
ES2082026T3 (es) Derivados de hidantoina.
BR9909961A (pt) Derivados de cadeia lateral alquila e alquenila funcionalizados de glicinamidas como inibidores de farnesil transferase
FI941417A (fi) Typpipitoiset heterosykliset yhdisteet
EA200200374A1 (ru) Производные хинолилпропилпиперидина, их получение и содержащие их композиции
AR245447A1 (es) Procedimiento para preparar derivados de 2,4-diamino-5-(biciclo-sustituido)metilpirimidinas.
ES2173477T3 (es) Derivados de tetrahidronaftaleno y su utilizacion terapeutica.
FR2383929A1 (fr) 1-hydroxy 2, 3, 4, 5-tetrahydro-1h-3-benzazepines substituees
FI862757A0 (fi) Pyridonkarbonsyraderivat och foerfarande foer framstaellning av dessa.
PE34996A1 (es) Nuevo derivado de pirrocarbazol
ATE11135T1 (de) Octahydrobenzo(f)chinolin-verbindungen.
DE3665711D1 (de) Novel guanidinomethylbenzoic acid derivatives
FR2362892A1 (fr) Compositions polymeres vulcanisables contenant des derives d'hydantoine
RS50033B (sr) Derivati etansulfonil-piperidina
SE8503557D0 (sv) Psychogeriatric 1-(2-pyrimidinyl)-piperazinyl derivatives of 1-pyrrolidin-2-ones
EA199900460A1 (ru) Производные бензолсульфоамида и лекарственные средства, содержащие упомянутые производные
FI872997A (fi) Amidderivat.
YU2994A (sh) Prolekovi antinflamatornih 3-acil-2-oksindol-1-karboksamida
ES8607958A1 (es) Procedimiento para preparar derivados de imidazol con actividad antitrombotica.
DE3781986T2 (de) Substituierte chinoxaline.
ATE74604T1 (de) Substituierte pyrimidochinoxaline.
ES8407028A1 (es) Un compuesto de imidazolilpropanol opticamente activo.
FI944207A (fi) Cyclohexane derivatives
GB1480892A (en) 3-nitropyrazole derivatives
ES8506702A1 (es) Un derivado del acido furiloxazolilacetico
ATE51227T1 (de) Chinatsalze der antimalarischen verbindung mefloquin.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 449079

Country of ref document: ES